IGFL1 Activators
The realm of IGFL1 activators primarily orbits around the intricate web of the IGF-1 signaling pathway, which plays a seminal role in the regulation of cell growth and survival. One of the noteworthy compounds is PDBu, known for its ability to activate protein kinase C (PKC). Given that PKC is integral to the phosphorylation events in the IGF-1 signaling pathway, the activation of PKC can indirectly influence the functional state of IGFL1.
Delving deeper into the molecular mechanisms, L-690,488 emerges as a selective activator of the IGF-1 receptor. By enhancing the receptor's activity, it sets forth a cascade of events in the IGF signaling pathway, which, in turn, may amplify the function of IGFL1. On a parallel axis, we recognize the role of cyclic AMP (cAMP) analogs, such as 8-Br-cAMP and Dibutyryl-cAMP, both of which activate protein kinase A (PKA). The interplay between PKA and the IGF pathway is intricate, and by modulating PKA activity, these compounds can pose indirect effects on IGFL1's function. Similarly, IBMX and Rolipram function by raising cAMP levels in cells, highlighting the importance of this secondary messenger in regulating pathways that may converge on the IGF family.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Diethylmaleate | 141-05-9 | sc-202577 | 5 g | $27.00 | 4 | |
An activator of glutathione transferases. Considering the link between redox status and the IGF signaling pathway, influencing cellular antioxidant status may indirectly modulate the function of proteins in the IGF family, including IGFL1. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
As a cAMP analog, it can activate protein kinase A (PKA). PKA plays a role in various cellular processes, and its activation might intersect with the IGF pathway, thus potentially affecting IGFL1 function. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A nonspecific PDE inhibitor, it elevates cellular cAMP levels, indirectly influencing pathways where cAMP plays a role. This can include IGF-associated pathways, and thus, may influence IGFL1 function. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
This PDE5 inhibitor, by modulating cyclic GMP levels, can affect pathways and cellular processes that are interlinked with the IGF pathway. This makes it a potential indirect activator of IGFL1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Another cAMP analog that can activate PKA. By influencing PKA-mediated cellular processes, this compound can indirectly modulate the IGF pathway and thus, IGFL1. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
As a PDE4 inhibitor, Rolipram increases intracellular cAMP levels, which can modulate pathways associated with the IGF family, potentially influencing IGFL1 function. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
By inhibiting PDE3 and PDE4, Zardaverine can elevate cAMP levels in cells. This modulation can affect various pathways including those associated with IGF, potentially affecting IGFL1. | ||||||
Ro 20-1724 | 29925-17-5 | sc-200709 sc-200709A sc-200709B | 100 mg 1 g 5 g | $87.00 $426.00 $1574.00 | 17 | |
This PDE4 inhibitor works by raising cAMP levels, which can indirectly influence the IGF pathway. Elevated cAMP may modulate various cellular processes that intersect with the IGF family, influencing IGFL1. | ||||||
Pentoxifylline | 6493-05-6 | sc-203184 | 1 g | $20.00 | 3 | |
Known as a PDE inhibitor, it can elevate cAMP and cGMP levels in cells. The subsequent pathway modulations can intersect with IGF-associated pathways, offering potential influence over IGFL1 function. | ||||||